Andy Upsall

Andy Upsall has a strong background in the biopharmaceutical industry, with experience ranging from being a Study Director at Covance to serving as a QC Virologist at MedImmune Vaccines. Currently, Andy is the CEO of Antibody Analytics, a company specializing in the functional characterization of antibody and antibody-like therapeutics. Prior to this, Andy was the Co-Founder & Director of R&D at Sartorius Stedim BioOutsource, where Andy played a crucial role in the company's development and eventual acquisition.